
Valens: a new name in the vaccine adjuvants market
By SPI PharmaAdjuvants are often key to improving the immunogenicity of vaccines and companies entering this market must make substantial investments to achieve the necessary...
Read more

A leading resource for the Pharmaceutical industry since 2002
Adjuvants are often key to improving the immunogenicity of vaccines and companies entering this market must make substantial investments to achieve the necessary...
Read more